Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- CheckyesterdayChange DetectedThe page shows minor formatting and layout changes with no changes to the study's key content.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a new MedlinePlus Genetics topic on schizophrenia, expanding core content related to a medical condition.SummaryDifference0.1%

- Check30 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check37 days agoChange Detected- Added revision tag v3.1.0. - Removed the MedlinePlus Genetics topic on Schizophrenia and the previous revision tag v3.0.2.SummaryDifference0.2%

- Check51 days agoChange DetectedAdded a MedlinePlus Genetics topic on Schizophrenia and updated the page revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

- Check58 days agoChange DetectedThe page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the topic of Schizophrenia related to MedlinePlus Genetics has been deleted.SummaryDifference0.3%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.